Chardan Capital Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Chardan Capital
Rating: 2.6
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
MGX Metagenomi	$1.65 -2.4%	11/20/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$15.00 -> $15.00	N/A	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 11/20/2024
IMRX Immuneering	$2.04	11/20/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$13.00 -> $13.00	N/A	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 11/20/2024
RGNX REGENXBIO	$9.63 +0.7%	11/20/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$52.00 -> $52.00	N/A	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 11/20/2024
ABUS Arbutus Biopharma	$3.44 -1.4%	11/20/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.50 -> $5.00	N/A	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/20/2024
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	11/18/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$62.00 -> $62.00	N/A	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/18/2024
OCGN Ocugen	$0.92 +4.6%	11/18/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00 -> $6.00	N/A	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/18/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
MGTX MeiraGTx	$5.82 -2.7%	11/18/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$36.00 -> $36.00	N/A	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 11/18/2024
NTLA Intellia Therapeutics	$13.12 -7.1%	11/18/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$88.00 -> $91.00	N/A	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024
FBRX Forte Biosciences	$13.55 +128.5%	11/15/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$3.00 -> $64.00	N/A	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 11/15/2024
CGTX Cognition Therapeutics	$0.44	11/15/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$11.00 -> $11.00	N/A	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/15/2024
CLSD Clearside Biomedical	$1.05 +1.9%	11/15/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$6.00 -> $6.00	N/A	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 11/15/2024
CRVO CervoMed	$9.64 -4.4%	11/14/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$55.00 -> $55.00	N/A	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 11/14/2024
TSHA Taysha Gene Therapies	$2.01 -5.2%	11/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00 -> $7.00	N/A	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/14/2024
PASG Passage Bio	$0.51 +6.2%	11/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00 -> $7.00	N/A	View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 11/14/2024
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	11/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$39.00 -> $39.00	N/A	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 11/14/2024
SLN Silence Therapeutics	$6.93 -0.6%	11/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$55.00 -> $55.00	N/A	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/14/2024
ALUR Allurion Technologies	$0.45 +9.7%	11/14/2024	Downgraded by	Chardan Capital	Analyst K. Nakae	Buy -> Neutral		N/A	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 11/14/2024
MCRB Seres Therapeutics	$0.81 +19.0%	11/13/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$1.25 -> $1.25	N/A	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 11/13/2024
RNA Avidity Biosciences	$43.65 +0.9%	11/13/2024	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$65.00 -> $65.00	N/A	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 11/13/2024
DYN Dyne Therapeutics	$29.99 +1.0%	11/13/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$50.00 -> $50.00	N/A	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 11/13/2024
OBIO Orchestra BioMed	$5.28 +2.1%	11/13/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$20.00 -> $20.00	N/A	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 11/13/2024
PRME Prime Medicine	$2.99 -5.7%	11/13/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$17.00 -> $15.00	N/A	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 11/13/2024
FEMY Femasys	$0.98 +10.1%	11/13/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$10.00 -> $8.00	N/A	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 11/13/2024
CRGX CARGO Therapeutics	$15.82 -1.8%	11/13/2024	Reiterated by	Chardan Capital	Analyst G. Livshits	Buy -> Buy	$28.00 -> $28.00	N/A	View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 11/13/2024
LXEO Lexeo Therapeutics	$6.12 +1.7%	11/13/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$23.00 -> $25.00	N/A	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/13/2024
SLDB Solid Biosciences	$4.96 -2.9%	11/11/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$15.00 -> $15.00	N/A	View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 11/11/2024
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	11/11/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$62.00 -> $62.00	N/A	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/11/2024
ZURA Zura Bio	$2.90 -7.9%	11/8/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$14.00 -> $12.00	N/A	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 11/8/2024
OCGN Ocugen	$0.92 +4.6%	11/8/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00 -> $6.00	N/A	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/8/2024
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	11/8/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$28.00 -> $33.00	N/A	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/8/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	11/7/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$25.00 -> $25.00	N/A	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 11/7/2024
TNYA Tenaya Therapeutics	$2.22 -2.2%	11/7/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$20.00 -> $18.00	N/A	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/7/2024
COYA Coya Therapeutics	$6.03 -0.7%	11/7/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$14.00 -> $14.00	N/A	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 11/7/2024
IPSC Century Therapeutics	$1.26 -1.6%	11/7/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$17.00 -> $11.00	N/A	View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 11/7/2024
ABUS Arbutus Biopharma	$3.44 -1.4%	11/6/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$4.00 -> $4.50	N/A	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/6/2024
EDIT Editas Medicine	$2.41 -2.8%	11/5/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$12.00 -> $12.00	Low	View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/5/2024
ALNY Alnylam Pharmaceuticals	$248.79 +6.2%	11/1/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$300.00 -> $300.00	High	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/1/2024
CGTX Cognition Therapeutics	$0.44	10/31/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$11.00 -> $11.00	Low	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 10/31/2024
COYA Coya Therapeutics	$6.03 -0.7%	10/30/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$14.00 -> $14.00	High	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 10/30/2024
RNA Avidity Biosciences	$43.65 +0.9%	10/30/2024	Target Raised by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$60.00 -> $65.00	High	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 10/30/2024
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	10/29/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$28.00 -> $28.00	Low	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 10/29/2024
LXEO Lexeo Therapeutics	$6.12 +1.7%	10/25/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$23.00 -> $23.00	Low	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 10/25/2024
NTLA Intellia Therapeutics	$13.12 -7.1%	10/24/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$94.00 -> $88.00	Low	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 10/24/2024
EDIT Editas Medicine	$2.41 -2.8%	10/22/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$20.00 -> $12.00	Medium	View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 10/22/2024
RGNX REGENXBIO	$9.63 +0.7%	10/22/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$52.00 -> $52.00	High	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 10/22/2024
CLSD Clearside Biomedical	$1.05 +1.9%	10/14/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$6.00 -> $6.00	Low	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 10/14/2024
ALNY Alnylam Pharmaceuticals	$248.79 +6.2%	10/11/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$300.00 -> $300.00	Low	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/11/2024
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	9/19/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$38.00 -> $39.00	High	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/19/2024
CRVO CervoMed	$9.64 -4.4%	9/18/2024	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$55.00	Medium	View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 9/18/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	9/9/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$25.00 -> $25.00	Medium	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 9/9/2024
MGX Metagenomi	$1.65 -2.4%	9/5/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$15.00 -> $15.00	Low	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 9/5/2024
ALUR Allurion Technologies	$0.45 +9.7%	8/22/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$5.00 -> $2.50	Low	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 8/22/2024
CLSD Clearside Biomedical	$1.05 +1.9%	8/21/2024	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$6.00	Low	View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 8/21/2024
FBRX Forte Biosciences	$13.55 +128.5%	8/19/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$3.00 -> $3.00	Low	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 8/19/2024
MGX Metagenomi	$1.65 -2.4%	8/19/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$17.00 -> $15.00	Low	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 8/19/2024
OTLK Outlook Therapeutics	$5.28 +1.0%	8/16/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$53.00 -> $53.00	Low	View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/16/2024
SLN Silence Therapeutics	$6.93 -0.6%	8/16/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$55.00 -> $55.00	Low	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/16/2024
FEMY Femasys	$0.98 +10.1%	8/14/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$12.00 -> $10.00	Low	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/14/2024
LXEO Lexeo Therapeutics	$6.12 +1.7%	8/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$23.00 -> $23.00	Low	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 8/14/2024
MCRB Seres Therapeutics	$0.81 +19.0%	8/14/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$1.25 -> $1.25	Low	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 8/14/2024
TSHA Taysha Gene Therapies	$2.01 -5.2%	8/13/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00 -> $7.00	Low	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/13/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	8/12/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$25.00 -> $25.00	Low	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/12/2024
GANX Gain Therapeutics	$1.66 -3.5%	8/9/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00 -> $6.00	Low	View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/9/2024
RNA Avidity Biosciences	$43.65 +0.9%	8/9/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$45.00 -> $60.00	Low	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2024
OMGA Omega Therapeutics	$0.79 +3.9%	8/7/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$7.00 -> $6.00	Low	View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/7/2024
IMRX Immuneering	$2.04	8/7/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$16.00 -> $12.00	Low	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2024
CRSP CRISPR Therapeutics	$47.26 +0.6%	8/6/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$112.00 -> $94.00	Low	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/6/2024
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	8/6/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$62.00 -> $62.00	Low	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/6/2024
KRYS Krystal Biotech	$178.10 +0.1%	8/5/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$153.00 -> $208.00	Low	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/5/2024
MGTX MeiraGTx	$5.82 -2.7%	7/31/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$36.00	Low	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 7/31/2024
ADVM Adverum Biotechnologies	$6.17 -1.3%	7/18/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$4.00 -> $40.00	Low	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 7/18/2024
ARWR Arrowhead Pharmaceuticals	$18.71 +0.6%	7/17/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$60.00 -> $60.00	Low	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/17/2024
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	7/17/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$38.00 -> $38.00	Low	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/17/2024
LXEO Lexeo Therapeutics	$6.12 +1.7%	7/15/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$23.00 -> $23.00	Low	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/15/2024
CRGX CARGO Therapeutics	$15.82 -1.8%	7/8/2024	Initiated by	Chardan Capital	Analyst G. Livshits	Buy	$28.00	Low	View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 7/8/2024
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	6/28/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$62.00 -> $62.00	Low	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 6/28/2024
SLN Silence Therapeutics	$6.93 -0.6%	6/28/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$42.00 -> $55.00	Low	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 6/28/2024
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	6/28/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$28.00 -> $28.00	Low	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 6/28/2024
ARWR Arrowhead Pharmaceuticals	$18.71 +0.6%	6/26/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$60.00 -> $60.00	Low	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/26/2024
TSHA Taysha Gene Therapies	$2.01 -5.2%	6/18/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00 -> $7.00	Low	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 6/18/2024
RNA Avidity Biosciences	$43.65 +0.9%	6/12/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$33.00 -> $45.00	Low	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/12/2024
OBIO Orchestra BioMed	$5.28 +2.1%	6/12/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$20.00 -> $20.00	Low	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 6/12/2024
OCS Oculis	$14.91 -0.7%	6/11/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$30.00 -> $30.00	Low	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 6/11/2024
CGTX Cognition Therapeutics	$0.44	6/6/2024	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$11.00	Low	View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/6/2024
COYA Coya Therapeutics	$6.03 -0.7%	6/5/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$14.00 -> $14.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/5/2024
ABUS Arbutus Biopharma	$3.44 -1.4%	6/5/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00 -> $4.00	Low	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 6/5/2024
IBIO iBio	$2.19 -1.8%	6/3/2024	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$5.00 -> $5.00	Low	View details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/3/2024
ARWR Arrowhead Pharmaceuticals	$18.71 +0.6%	6/3/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$60.00 -> $60.00	Low	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/3/2024
NVX NOVONIX	$1.97 -3.9%	5/30/2024	Initiated by	Chardan Capital	Analyst B. Dobson	Buy	$4.00	Low	View details for Chardan Capital rating of NOVONIX (NASDAQ:NVX) on 5/30/2024
IBIO iBio	$2.19 -1.8%	5/28/2024	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$5.00	Low	View details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/28/2024
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
CRGO Freightos	$1.91 +4.4%	5/23/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$8.00 -> $6.00	Low	View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 5/23/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	5/21/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$25.00 -> $25.00	Low	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/21/2024
DYN Dyne Therapeutics	$29.99 +1.0%	5/21/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$31.00 -> $42.00	Low	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/21/2024
BMTX BM Technologies	$4.77 +0.4%	5/20/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$8.00 -> $8.00	Low	View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 5/20/2024
SLN Silence Therapeutics	$6.93 -0.6%	5/17/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$42.00 -> $42.00	Low	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 5/17/2024
ALUR Allurion Technologies	$0.45 +9.7%	5/15/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00 -> $5.00	Low	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 5/15/2024
OCGN Ocugen	$0.92 +4.6%	5/15/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00 -> $5.00	Low	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/15/2024
CLSK CleanSpark	$14.00 -0.8%	5/13/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$26.00 -> $26.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/13/2024
RNA Avidity Biosciences	$43.65 +0.9%	5/10/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$33.00 -> $33.00	Low	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/10/2024
PRQR ProQR Therapeutics	$3.67 +1.9%	5/10/2024	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$2.50 -> $2.50	Low	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024
ARWR Arrowhead Pharmaceuticals	$18.71 +0.6%	5/10/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$60.00 -> $60.00	Low	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/10/2024
PET Wag! Group	$0.21 +23.5%	5/10/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$8.00 -> $8.00	Low	View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 5/10/2024
COYA Coya Therapeutics	$6.03 -0.7%	5/9/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$14.00 -> $14.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/9/2024
VLN Valens Semiconductor	$1.96 +1.0%	5/9/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00 -> $4.00	Low	View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/9/2024
SLDP Solid Power	$1.06 +1.9%	5/8/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00 -> $5.00	Low	View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 5/8/2024
MCRB Seres Therapeutics	$0.81 +19.0%	5/8/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$8.00 -> $6.00	Low	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2024
PLBY PLBY Group	$1.13	5/8/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00 -> $4.00	Low	View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 5/8/2024
MARA MARA	$22.63 +13.9%	5/8/2024	Target Lowered by	Chardan Capital	-	Neutral -> Neutral	$30.00 -> $21.00	Low	View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 5/8/2024
CLSK CleanSpark	$14.00 -0.8%	5/7/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$26.00 -> $26.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/7/2024
OMGA Omega Therapeutics	$0.79 +3.9%	5/7/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00 -> $7.00	Low	View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 5/7/2024
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	5/7/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$39.00 -> $28.00	Low	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/7/2024
DYN Dyne Therapeutics	$29.99 +1.0%	5/6/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$31.00 -> $31.00	Low	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024
ABUS Arbutus Biopharma	$3.44 -1.4%	5/3/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00 -> $4.00	Low	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 5/3/2024
ALNY Alnylam Pharmaceuticals	$248.79 +6.2%	5/3/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$225.00 -> $225.00	Low	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/3/2024
COYA Coya Therapeutics	$6.03 -0.7%	4/29/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$14.00 -> $14.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/29/2024
BMTX BM Technologies	$4.77 +0.4%	4/22/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$8.00 -> $8.00	Low	View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/22/2024
OCGN Ocugen	$0.92 +4.6%	4/22/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$4.00 -> $5.00	Low	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/22/2024
PRME Prime Medicine	$2.99 -5.7%	4/22/2024	Initiated by	Chardan Capital	-	Buy	$17.00	Low	View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 4/22/2024
LICY Li-Cycle	$2.11 -8.3%	4/19/2024	Reiterated by	Chardan Capital	-	Neutral -> Neutral	$6.00	Low	View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 4/19/2024
DFLI Dragonfly Energy	$0.40 +8.2%	4/16/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$3.00	Low	View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 4/16/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	4/16/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$25.00	Low	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024
NRGV Energy Vault	$1.48 -8.7%	4/8/2024	Reiterated by	Chardan Capital	-	Buy -> Sell	$7.00 -> $0.75	Low	View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 4/8/2024
ACHL Achilles Therapeutics	$1.07 +1.9%	4/5/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$11.00 -> $6.00	Low	View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 4/5/2024
BMTX BM Technologies	$4.77 +0.4%	4/4/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$8.00	Low	View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/4/2024
ALUR Allurion Technologies	$0.45 +9.7%	4/4/2024	Initiated by	Chardan Capital	-	Buy	$5.00	Low	View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 4/4/2024
OUST Ouster	$8.89 -1.4%	4/3/2024	Reiterated by	Chardan Capital	-	Buy -> Neutral	$10.00	Low	View details for Chardan Capital rating of Ouster (NYSE:OUST) on 4/3/2024
SABS SAB Biotherapeutics	$3.06 -5.6%	4/2/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$3.00 -> $25.00	Low	View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024
FEMY Femasys	$0.98 +10.1%	4/1/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$12.00	Low	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 4/1/2024
OMGA Omega Therapeutics	$0.79 +3.9%	4/1/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$12.00 -> $7.00	Low	View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 4/1/2024
OBIO Orchestra BioMed	$5.28 +2.1%	3/28/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$20.00	Low	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/28/2024
MGX Metagenomi	$1.65 -2.4%	3/28/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$21.00	Low	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/28/2024
GANX Gain Therapeutics	$1.66 -3.5%	3/27/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00	Low	View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2024
PLBY PLBY Group	$1.13	3/26/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00	Low	View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 3/26/2024
TNYA Tenaya Therapeutics	$2.22 -2.2%	3/21/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$20.00	Low	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/21/2024
FEMY Femasys	$0.98 +10.1%	3/21/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$12.00	Low	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/21/2024
TSHA Taysha Gene Therapies	$2.01 -5.2%	3/21/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$5.00 -> $7.00	Low	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/21/2024
COYA Coya Therapeutics	$6.03 -0.7%	3/20/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$11.00 -> $14.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2024
OCS Oculis	$14.91 -0.7%	3/19/2024	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy -> Buy	$30.00	Low	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/19/2024
ADVM Adverum Biotechnologies	$6.17 -1.3%	3/19/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00	Low	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/19/2024
PRQR ProQR Therapeutics	$3.67 +1.9%	3/14/2024	Target Raised by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$2.00 -> $2.50	Low	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
SLN Silence Therapeutics	$6.93 -0.6%	3/14/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$26.00 -> $42.00	Low	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/14/2024
IMRX Immuneering	$2.04	3/15/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$21.00 -> $16.00	N/A	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/15/2024
GWH ESS Tech	$5.15 -0.4%	3/15/2024	Target Lowered by	Chardan Capital	-	Neutral -> Neutral	$28.50 -> $12.00	N/A	View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/15/2024
NRGV Energy Vault	$1.48 -8.7%	3/18/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00	Low	View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/18/2024
DYN Dyne Therapeutics	$29.99 +1.0%	3/8/2024	Target Raised by	Chardan Capital	-	Buy	$20.00 -> $31.00	Low	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/8/2024
RGNX REGENXBIO	$9.63 +0.7%	3/7/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$52.00	Low	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/7/2024
MCRB Seres Therapeutics	$0.81 +19.0%	3/6/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$10.00 -> $8.00	Low	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024
MGX Metagenomi	$1.65 -2.4%	3/5/2024	Initiated by	Chardan Capital	-	Buy	$21.00	Low	View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/5/2024
MARA MARA	$22.63 +13.9%	3/4/2024	Target Raised by	Chardan Capital	-	Neutral -> Neutral	$26.00 -> $30.00	Low	View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 3/4/2024
CLSK CleanSpark	$14.00 -0.8%	3/4/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$13.00 -> $26.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 3/4/2024
ABUS Arbutus Biopharma	$3.44 -1.4%	3/1/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$4.00	Low	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024
RNA Avidity Biosciences	$43.65 +0.9%	2/29/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$23.00	Low	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/29/2024
SLDP Solid Power	$1.06 +1.9%	2/28/2024	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00	Low	View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 2/28/2024
CRSP CRISPR Therapeutics	$47.26 +0.6%	2/22/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$110.00 -> $112.00	Low	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2024
IOVA Iovance Biotherapeutics	$8.14 -0.6%	2/20/2024	Target Raised by	Chardan Capital	-	Buy -> Buy	$29.00 -> $34.00	Low	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/20/2024
ALNY Alnylam Pharmaceuticals	$248.79 +6.2%	2/16/2024	Target Lowered by	Chardan Capital	-	Buy -> Buy	$250.00 -> $225.00	Low	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/16/2024
OTLK Outlook Therapeutics	$5.28 +1.0%	2/15/2024	Upgraded by	Chardan Capital	Analyst D. Gataulin	Neutral -> Buy	$60.00	Low	View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/15/2024
SYBX Synlogic	$1.44 +5.9%	2/9/2024	Downgraded by	Chardan Capital	Analyst K. Nakae	Buy -> Neutral		Low	View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 2/9/2024
OCS Oculis	$14.91 -0.7%	12/5/2023	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$30.00	Low	View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 12/5/2023
LXEO Lexeo Therapeutics	$6.12 +1.7%	11/28/2023	Initiated by	Chardan Capital	Analyst G. Livshits	Buy	$23.00	Low	View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023
LICY Li-Cycle	$2.11 -8.3%	11/16/2023	Downgraded by	Chardan Capital	-	Buy -> Neutral		Low	View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 11/16/2023
PRQR ProQR Therapeutics	$3.67 +1.9%	11/8/2023	Upgraded by	Chardan Capital	Analyst K. Nakae	Neutral -> Buy	$2.00	Low	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 11/8/2023
WBX Wallbox	$0.59 +3.5%	10/19/2023	Downgraded by	Chardan Capital	-	Buy -> Neutral	$2.25	Low	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 10/19/2023
VYGR Voyager Therapeutics	$5.36 +1.7%	9/18/2023	Reiterated by	Chardan Capital	Analyst G. Livshits	Neutral		Low	View details for Chardan Capital rating of Voyager Therapeutics (NASDAQ:VYGR) on 9/18/2023
OTLK Outlook Therapeutics	$5.28 +1.0%	8/31/2023	Downgraded by	Chardan Capital	Analyst D. Gataulin	Buy -> Neutral		Low	View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/31/2023
ZURA Zura Bio	$2.90 -7.9%	8/17/2023	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy		Low	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/17/2023
QURE uniQure	$5.70 -2.1%	8/17/2023	Reiterated by	Chardan Capital	Analyst Y. Livshits	Buy		Low	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/17/2023
PLBY PLBY Group	$1.13	8/17/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$5.00 -> $4.00	Low	View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 8/17/2023
SLN Silence Therapeutics	$6.93 -0.6%	8/17/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$26.00	Low	View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/17/2023
IOVA Iovance Biotherapeutics	$8.14 -0.6%	8/16/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$29.00	Low	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/16/2023
LICY Li-Cycle	$2.11 -8.3%	8/16/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$64.00 -> $56.00	Low	View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/16/2023
VLN Valens Semiconductor	$1.96 +1.0%	8/15/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$9.00 -> $5.00	Low	View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 8/15/2023
OTLK Outlook Therapeutics	$5.28 +1.0%	8/15/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$200.00	Low	View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/15/2023
TSHA Taysha Gene Therapies	$2.01 -5.2%	8/15/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00	Low	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/15/2023
TNYA Tenaya Therapeutics	$2.22 -2.2%	8/14/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$23.00	Low	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/14/2023
GANX Gain Therapeutics	$1.66 -3.5%	8/14/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00	Low	View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2023
SYBX Synlogic	$1.44 +5.9%	8/11/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$90.00	Low	View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 8/11/2023
CLSK CleanSpark	$14.00 -0.8%	8/11/2023	Target Raised by	Chardan Capital	-	Buy -> Buy	$10.00 -> $11.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 8/11/2023
MGTX MeiraGTx	$5.82 -2.7%	8/11/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$41.00	Low	View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/11/2023
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	8/11/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$31.00	Low	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/11/2023
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	8/11/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$61.00	Low	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2023
FEMY Femasys	$0.98 +10.1%	8/11/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$10.00	Low	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/11/2023
ADVM Adverum Biotechnologies	$6.17 -1.3%	8/11/2023	Upgraded by	Chardan Capital	Analyst D. Gataulin	Neutral -> Buy	$20.00 -> $40.00	Low	View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/11/2023
OBIO Orchestra BioMed	$5.28 +2.1%	8/9/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy -> Buy	$20.00	Low	View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/9/2023
COYA Coya Therapeutics	$6.03 -0.7%	8/9/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$11.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/9/2023
NRGV Energy Vault	$1.48 -8.7%	8/9/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00	Low	View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/9/2023
IOVA Iovance Biotherapeutics	$8.14 -0.6%	8/9/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$29.00	Low	View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/9/2023
PET Wag! Group	$0.21 +23.5%	8/10/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$8.00	N/A	View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 8/10/2023
SLDP Solid Power	$1.06 +1.9%	8/10/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$5.00	N/A	View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 8/10/2023
IPSC Century Therapeutics	$1.26 -1.6%	8/9/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$19.00 -> $17.00	Low	View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 8/9/2023
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
RNA Avidity Biosciences	$43.65 +0.9%	8/9/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$27.00 -> $23.00	Low	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2023
ARWR Arrowhead Pharmaceuticals	$18.71 +0.6%	8/8/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$60.00	Low	View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/8/2023
ALNY Alnylam Pharmaceuticals	$248.79 +6.2%	8/8/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$250.00	Low	View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/8/2023
CRSP CRISPR Therapeutics	$47.26 +0.6%	8/7/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$123.00 -> $110.00	Low	View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/7/2023
KRYS Krystal Biotech	$178.10 +0.1%	8/7/2023	Target Raised by	Chardan Capital	-	Buy -> Buy	$148.00 -> $153.00	Low	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/7/2023
PASG Passage Bio	$0.51 +6.2%	8/7/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$11.00 -> $9.00	Low	View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 8/7/2023
MARA MARA	$22.63 +13.9%	8/7/2023	Downgraded by	Chardan Capital	-	Buy -> Neutral	$15.00	Low	View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 8/7/2023
NTLA Intellia Therapeutics	$13.12 -7.1%	8/7/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$107.00	Low	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/7/2023
ACHL Achilles Therapeutics	$1.07 +1.9%	8/7/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$11.00	Low	View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 8/7/2023
IMRX Immuneering	$2.04	8/7/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$22.00	Low	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2023
ABUS Arbutus Biopharma	$3.44 -1.4%	8/4/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$6.00	Low	View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/4/2023
DYN Dyne Therapeutics	$29.99 +1.0%	8/4/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$20.00	Low	View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 8/4/2023
OMGA Omega Therapeutics	$0.79 +3.9%	8/4/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$12.00	Low	View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/4/2023
PRQR ProQR Therapeutics	$3.67 +1.9%	8/4/2023	Reiterated by	Chardan Capital	-	Neutral -> Neutral	$2.00	Low	View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/4/2023
MESO Mesoblast	$10.33 -4.5%	8/4/2023	Target Lowered by	Chardan Capital	-	Sell -> Sell	$4.00 -> $3.00	Low	View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 8/4/2023
RGNX REGENXBIO	$9.63 +0.7%	8/3/2023	Reiterated by	Chardan Capital	-	Buy	$55.00	Low	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/3/2023
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	8/3/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$22.00	Low	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 8/3/2023
EDIT Editas Medicine	$2.41 -2.8%	8/2/2023	Target Lowered by	Chardan Capital	-	Buy -> Buy	$22.00 -> $19.00	Low	View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 8/2/2023
NRGV Energy Vault	$1.48 -8.7%	8/2/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$7.00	Low	View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/2/2023
LICY Li-Cycle	$2.11 -8.3%	8/1/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$64.00	Low	View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/1/2023
BMTX BM Technologies	$4.77 +0.4%	7/26/2023	Target Lowered by	Chardan Capital	-	Buy	$13.00 -> $8.00	Low	View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 7/26/2023
KOD Kodiak Sciences	$5.79 +2.7%	7/25/2023	Downgraded by	Chardan Capital	Analyst D. Gataulin	Buy -> Neutral		Low	View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 7/25/2023
CLSK CleanSpark	$14.00 -0.8%	7/24/2023	Target Raised by	Chardan Capital	-	Buy	$6.00 -> $10.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 7/24/2023
FBRX Forte Biosciences	$13.55 +128.5%	7/16/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Neutral		Low	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 7/16/2023
DFLI Dragonfly Energy	$0.40 +8.2%	7/13/2023	Reiterated by	Chardan Capital	-	Buy -> Buy	$10.00	Low	View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 7/13/2023
OUST Ouster	$8.89 -1.4%	7/13/2023	Upgraded by	Chardan Capital	-	Neutral -> Buy	$10.00	Low	View details for Chardan Capital rating of Ouster (NYSE:OUST) on 7/13/2023
WBX Wallbox	$0.59 +3.5%	6/30/2023	Target Lowered by	Chardan Capital	-	Buy	$12.00 -> $11.00	Low	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 6/30/2023
ZURA Zura Bio	$2.90 -7.9%	7/10/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 7/10/2023
XLO Xilio Therapeutics	$0.94 -7.8%	7/10/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low	View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 7/10/2023
QURE uniQure	$5.70 -2.1%	7/10/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/10/2023
IMVT Immunovant	$26.17 +3.8%	7/10/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low	View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 7/10/2023
IMNM Immunome	$9.33 -0.6%	7/10/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low	View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 7/10/2023
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	7/11/2023	Target Raised by	Chardan Capital	-		$30.00 -> $31.00	Low	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/11/2023
FDMT 4D Molecular Therapeutics	$8.41 -3.0%	7/5/2023	Initiated by	Chardan Capital	-	Buy	$30.00	Low	View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/5/2023
ZURA Zura Bio	$2.90 -7.9%	6/14/2023	Initiated by	Chardan Capital	Analyst M. Barcus	Buy	$14.00	Low	View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 6/14/2023
NTLA Intellia Therapeutics	$13.12 -7.1%	6/13/2023	Target Lowered by	Chardan Capital	-		$111.00 -> $107.00	Low	View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/13/2023
COYA Coya Therapeutics	$6.03 -0.7%	6/7/2023	Target Raised by	Chardan Capital	Analyst K. Nakae		$9.00 -> $11.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/7/2023
SYBX Synlogic	$1.44 +5.9%	6/6/2023	Target Raised by	Chardan Capital	-		$82.50 -> $90.00	Low	View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 6/6/2023
MESO Mesoblast	$10.33 -4.5%	5/30/2023	Target Lowered by	Chardan Capital	-		$5.00 -> $4.00	Low	View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 5/30/2023
IMVT Immunovant	$26.17 +3.8%	5/22/2023	Target Raised by	Chardan Capital	-		$21.00 -> $32.00	Low	View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 5/22/2023
KRYS Krystal Biotech	$178.10 +0.1%	5/22/2023	Target Raised by	Chardan Capital	-		$133.00 -> $148.00	Low	View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/22/2023
EYPT EyePoint Pharmaceuticals	$8.96 -2.8%	5/18/2023	Target Raised by	Chardan Capital	-		$21.00 -> $22.00	Low	View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/18/2023
FBRX Forte Biosciences	$13.55 +128.5%	5/15/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Neutral		Low	View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 5/15/2023
TNYA Tenaya Therapeutics	$2.22 -2.2%	5/11/2023	Target Lowered by	Chardan Capital	-		$24.00 -> $23.00	Low	View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/11/2023
VLN Valens Semiconductor	$1.96 +1.0%	5/11/2023	Target Lowered by	Chardan Capital	-	Buy	$13.00 -> $12.00	Low	View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/11/2023
QURE uniQure	$5.70 -2.1%	5/10/2023	Target Lowered by	Chardan Capital	-		$60.00 -> $56.00	Low	View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/10/2023
OCGN Ocugen	$0.92 +4.6%	5/7/2023	Target Raised by	Chardan Capital	Analyst D. Gataulin		$3.50 -> $4.00	Low	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/7/2023
RCKT Rocket Pharmaceuticals	$13.04 -0.9%	5/5/2023	Target Lowered by	Chardan Capital	-		$63.00 -> $61.00	Low	View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/5/2023
RGNX REGENXBIO	$9.63 +0.7%	5/4/2023	Target Lowered by	Chardan Capital	-		$61.00 -> $55.00	Low	View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 5/4/2023
MCRB Seres Therapeutics	$0.81 +19.0%	4/28/2023	Target Lowered by	Chardan Capital	-		$12.00 -> $10.00	Low	View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 4/28/2023
WBX Wallbox	$0.59 +3.5%	4/18/2023	Reiterated by	Chardan Capital	-	Buy	$12.00	Low	View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/18/2023
IMRX Immuneering	$2.04	4/18/2023	Target Raised by	Chardan Capital	-	Buy	$18.00 -> $22.00	Low	View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 4/18/2023
OCGN Ocugen	$0.92 +4.6%	4/14/2023	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy	$3.50	Low	View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/14/2023
CLSK CleanSpark	$14.00 -0.8%	4/17/2023	Reiterated by	Chardan Capital	-	Buy	$5.00	Low	View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 4/17/2023
MARA MARA	$22.63 +13.9%	4/3/2023	Reiterated by	Chardan Capital	-	Buy	$15.00	Low	View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 4/3/2023
COYA Coya Therapeutics	$6.03 -0.7%	3/30/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy	$9.00	Low	View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/30/2023
RNA Avidity Biosciences	$43.65 +0.9%	3/31/2023	Reiterated by	Chardan Capital	-	Buy	$27.00	N/A	View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/31/2023
FEMY Femasys	$0.98 +10.1%	3/30/2023	Target Lowered by	Chardan Capital	-	Buy	$12.00 -> $10.00	Low	View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/30/2023
TSHA Taysha Gene Therapies	$2.01 -5.2%	3/29/2023	Target Lowered by	Chardan Capital	-	Buy	$6.00 -> $5.00	Low	View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/29/2023
SYBX Synlogic	$1.44 +5.9%	3/29/2023	Target Lowered by	Chardan Capital	-	Buy	$105.00 -> $82.50	Low	View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 3/29/2023

MarketBeat Community Rating for Chardan Capital

Community Ranking:		2.6 out of 5 ( 2.6 of 5 stars)
Outperform Votes:		31,757 (Vote Outperform)
Underperform Votes:		28,489 (Vote Underperform)
Total Votes:		60,246

MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chardan Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Chardan Capital

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Chardan Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Chardan Capital

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools